SCHEMBL20296

SCHEMBL20296

O=C(O)[C@@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122166 1.00
SCHEMBL1527305 1.00
Methane SCHEMBL27771786 0.97
Ammonia Solution, Strong SCHEMBL31008744 0.97
Hydrochloric Acid SCHEMBL3623568 0.97
Hydrochloric Acid SCHEMBL3540925 0.97
SCHEMBL17743461 0.97
Hydrochloric Acid SCHEMBL3540927 0.97
SCHEMBL8077380 0.92 MEN1 (0.46)
Acetic Acid SCHEMBL4726910 0.92 MEN1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122094701-A TLR3 binding bicyclic peptide ligands 2026-05-26 CN claimed
CN-122063036-A Evaluation method for influence of micro-plastic on facility soil function under temperature mediation 四川农业大学 2026-05-19 CN claimed
US-20260115256-A1 HUMAN AMYLIN ANALOG, AND DERIVATIVE THEREOF AND USE THEREOF HANGZHOU SCIWIND BIOSCIENCES CO., LTD. (CN) 2026-04-30 US claimed
EP-4727655-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
EP-4727654-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
EP-4727653-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
US-12521455-B2 Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof RADIONETICS ONCOLOGY, INC. (US) 2026-01-13 US claimed
US-20250340595-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) BICYCLETX LTD (GB) 2025-11-06 US claimed
EP-3727462-B1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2 BICYCLERD LTD (GB) 2025-11-05 EP claimed
WO-2025217074-A1 KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY, INC. (US) 2025-10-16 WO claimed
EP-0871491-A2 POLYMERS DANBIOSYST UK LIMITED (GB) 1998-10-21 EP claimed
EP-0811004-A4 MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS AEROJET GENERAL CO (US) 1998-09-30 EP claimed
WO-1998002568-A1 THE BIORESOLUTION OF N-ACYLAZETIDINE-2-CARBOXYLIC ACIDS ASTRA AKTIEBOLAG (SE) 1998-01-22 WO claimed
WO-1998002417-A1 PROCESS FOR THE PRODUCTION OF ENANTIOMERICALLY ENRICHED N-ACYLAZETIDINE-2-CARBOXYLIC ACIDS ASTRA AKTIEBOLAG (SE) 1998-01-22 WO claimed
EP-0811004-A1 MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS AEROJET-GENERAL CORPORATION (US) 1997-12-10 EP claimed
WO-1997025067-A2 POLYMERS DANBIOSYST UK LIMITED (GB) 1997-07-17 WO claimed
EP-0619824-A1 TROPHOBLAST INTERFERONS AND THEIR USE Ebbesen, Peter (DK) 1994-10-19 EP claimed
WO-1993012146-A1 TROPHOBLAST INTERFERONS AND THEIR USE LANDSFORENINGEN TIL KRAEFTENS BEKAEMPELSE (DK) 1993-06-24 WO claimed
EP-0264184-B1 MOLYBDENUM/ALKALI METAL/ETHYLENE GLYCOL COMPLEXES USEFUL AS EPOXIDATION CATALYSTS AND METHOD FOR MAKING THE SAME TEXACO DEVELOPMENT CORPORATION (US) 1990-12-19 EP claimed
EP-0343293-A1 Method of making molybdenum/alkylene complexes useful as epoxidation catalysts TEXACO DEVELOPMENT CORPORATION (US) 1989-11-29 EP claimed